2019
DOI: 10.1007/s10096-019-03567-2
|View full text |Cite
|
Sign up to set email alerts
|

Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection

Abstract: The severity of bloodstream infections (BSI) depends on pathogen, source, and host factors. Secretory leukocyte protease inhibitor (SLPI) counteracts tissue damage, balances inflammation, and is increased in pneumonia and sepsis. We aimed to evaluate whether SLPI production differs depending on etiology, disease severity, and sex in BSI and to correlate SLPI with markers of inflammation and immunosuppression. Of the adult patients with BSI, 109 were included and sampled repeatedly, from hospital admission thro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 49 publications
0
2
0
1
Order By: Relevance
“…Our scRNAseq analyses also revealed the induction of SLPI, an anti-inflammatory molecule; IL-1R2, an antagonist of IL-1 signaling. Both of SLPI and IL-1R2 were shown to be elevated in septic monocytes collected from human patients (57,58). Collectively, the elevation of immunosuppressors such as PD-L1, SLPI and IL-1R2 and reduction of co-stimulatory molecules such as CD86 contribute to the immuno-suppressive phenotype characteristics of exhausted monocytes observed in clinical sepsis patients (11,31,57,58).…”
Section: Discussionmentioning
confidence: 99%
“…Our scRNAseq analyses also revealed the induction of SLPI, an anti-inflammatory molecule; IL-1R2, an antagonist of IL-1 signaling. Both of SLPI and IL-1R2 were shown to be elevated in septic monocytes collected from human patients (57,58). Collectively, the elevation of immunosuppressors such as PD-L1, SLPI and IL-1R2 and reduction of co-stimulatory molecules such as CD86 contribute to the immuno-suppressive phenotype characteristics of exhausted monocytes observed in clinical sepsis patients (11,31,57,58).…”
Section: Discussionmentioning
confidence: 99%
“…In peripheral circulation, the mean SLPI concentration showed a significant ( p < .05) increase in the P‐sepsis+ group as compared to the P‐sepsis− group and increased concentration of SLPI in the P‐sepsis+ bitch may be indicative of sepsis associated organ dysfunction. SLPI is known for its diverse immunological functions and to counteract the ill effects of tissue damage and inflammation in sepsis (Lange et al, 2019). The SLPI concentrations using a positive correlation of IL8 and SLPI expressions (data not shown) in the P‐sepsis+ bitch endometrium suggest the role of pro‐inflammatory cytokines in the regulation of SLPI production (VanWetering et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…Одним із протеїнів вродженого імунного захисту в респіраторних секретах є секреторний інгібітор протеази лейкоцитів (SLPI), який експресується макрофагами, нейтрофілами та епітелієм слизових оболонок [5]. Поси-лений синтез SLPI індукується інфекційними антигенами при патологічному процесі [5]. SLPI може бути одним із маркерів прогнозування стану гепатобіліарної системи при пневмонії у дітей раннього віку.…”
Section: вступunclassified